TGFB1 and neoplasm: The above results suggested that FAP+ fibroblasts might confer enhanced metastatic ability to tumor cells with low metastatic propensity through the TGF-β signaling pathway in vivo, whereas the CCN2 inhibitor significantly blocked this effect in metastatic ability.